Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.17B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.37B |
| 4 |
Linde
LIN
|
+$756M |
| 5 |
DuPont de Nemours
DD
|
+$595M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.51B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$315M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$314M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
PPLI
People Inc
PPLI
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.07% |
| 2 | Financials | 6.12% |
| 3 | Healthcare | 5.17% |
| 4 | Consumer Discretionary | 4.88% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Triumph Financial Inc
TFIN
$1.88B
| $1.1M | ﹤0.01% |
35,470
+5,898
| +20% | +$161K |
|
|
ENDP
2577
DELISTED
Endo International plc
ENDP
| $1.1M | ﹤0.01% |
334,848
+60,608
| +22% | +$194K |
|
|
VIVO
2578
DELISTED
Meridian Bioscience Inc
VIVO
| $1.1M | ﹤0.01% |
65,062
+21,888
| +51% | +$425K |
|
2579
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$440M
| $1.1M | ﹤0.01% |
9,900
| – | – |
|
2580
Crane NXT
CXT
$2.96B
| $1.1M | ﹤0.01% |
62,961
+9,449
| +18% | +$187K |
|
2581
TriCo Bancshares
TCBK
$1.86B
| $1.1M | ﹤0.01% |
44,762
-2,617
| -6% | -$73K |
|
2582
CALL
GoPro
GPRO
$109M
| $1.09M | ﹤0.01% |
241,600
-1,500
| -0.6% | -$7.04K |
|
2583
Martin Midstream Partners
MMLP
$95.5M
| $1.09M | ﹤0.01% |
+934,800
| New | +$1.56M |
|
2584
Cooper-Standard Automotive
CPS
$504M
| $1.09M | ﹤0.01% |
82,759
+6,076
| +8% | +$84.5K |
|
2585
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
| $1.09M | ﹤0.01% |
9,900
| – | – |
|
2586
Wintrust Financial
WTFC
$11B
| $1.09M | ﹤0.01% |
27,273
-3,904
| -13% | -$167K |
|
|
ORAN
2587
DELISTED
Orange
ORAN
| $1.09M | ﹤0.01% |
105,344
-142,605
| -58% | -$1.65M |
|
|
AVNS
2588
DELISTED
Avanos Medical
AVNS
| $1.09M | ﹤0.01% |
32,834
-2,703
| -8% | -$86.4K |
|
2589
PUT
T. Rowe Price
TROW
$23.5B
| $1.09M | ﹤0.01% |
8,500
| – | – |
|
2590
Ormat Technologies
ORA
$7.07B
| $1.09M | ﹤0.01% |
18,425
-24,161
| -57% | -$1.46M |
|
2591
Atkore
ATKR
$3.17B
| $1.09M | ﹤0.01% |
47,790
-16,587
| -26% | -$449K |
|
2592
PUT
Genuine Parts
GPC
$18.6B
| $1.08M | ﹤0.01% |
11,400
| – | – |
|
2593
PUT
Molson Coors Class B
TAP
$7.91B
| $1.08M | ﹤0.01% |
32,300
-70,000
| -68% | -$2.53M |
|
2594
Provident Financial Services
PFS
$3.24B
| $1.08M | ﹤0.01% |
88,247
+32,942
| +60% | +$444K |
|
|
PRA
2595
DELISTED
ProAssurance
PRA
| $1.07M | ﹤0.01% |
68,639
+15,751
| +30% | +$234K |
|
2596
CALL
AngloGold Ashanti
AU
$48.6B
| $1.07M | ﹤0.01% |
40,600
-107,900
| -73% | -$3.23M |
|
2597
Employers Holdings
EIG
$870M
| $1.07M | ﹤0.01% |
35,281
+3,573
| +11% | +$113K |
|
2598
PUT
LivePerson
LPSN
$36.3M
| $1.07M | ﹤0.01% |
1,367
| – | – |
|
2599
PUT
Toll Brothers
TOL
$13.8B
| $1.07M | ﹤0.01% |
21,900
-6,300
| -22% | -$255K |
|
2600
Cushman & Wakefield Ltd
CWK
$3.36B
| $1.06M | ﹤0.01% |
101,197
+37,057
| +58% | +$416K |
|
Similar funds
Barclays's Q3 2020 Portfolio in Review
As of Q3 2020, Barclays held 5,906 positions worth $168B, up 30% from $129B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays deployed $26.3B of net new capital in Q3 2020, opening 241 new positions and adding to 1,886 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $1.51B trimmed.
- Barclays's largest Q3 2020 buy was State Street SPDR Bloomberg High Yield Bond ETF: 771,265 shares worth $80.4M.
- Barclays added most to Visa in Q3 2020, an estimated $2.17B increase.
- Barclays's biggest Q3 2020 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $1.51B.
- Barclays fully exited People Inc in Q3 2020, selling an estimated $239M.
- Barclays's ten largest holdings make up 34% of its $168B portfolio in Q3 2020.
- Barclays opened 241 new positions and closed 676 in Q3 2020.
- Barclays's portfolio value rose 30% quarter-over-quarter to $168B.
Based on Barclays's 13F filing for Q3 2020, filed 12 Nov 2020.